Towards Healthcare

NEWS & INSIGHTS

Stay ahead of the curve with in-depth coverage of the latest breakthroughs, emerging trends, strategic developments, and transformative innovations shaping the future of healthcare, science, technology, and global business.

BioHarvest Sciences' new product to accelerate growth in the US Electrolytes Drink Market
Date 08 December 2025

BioHarvest Sciences' new product to accelerate growth in the US Electrolytes Drink Market

Announcement BioHarvest, a leading company innovating its authorised Botanical Synthesis technology platform, has proudly launched its VINIA Blood Flow Hydration™ for and in the U.S. It’s...

Microbiome Labs' new formula, a relief for digestive issues
Date 08 December 2025

Microbiome Labs' new formula, a relief for digestive issues

Announcement Microbiome Labs, a champion in microbiome-related solutions, inaugurated DigestMate™, a probiotic and 2-in-1 digestive enzyme formula. As observed, the digestive health issues have...

Capricor returns to the FDA's doorstep for DMD Cardiomyopathy Therapy
Date 08 December 2025

Capricor returns to the FDA's doorstep for DMD Cardiomyopathy Therapy

Announcement Capricor has again come up with the pivotal results for DMD cardiomyopathy therapy after the rejection. After six months of receiving the shocking rejection for Capricor’s cell th...

New UK/EU Rules and technologies lined up for next year
Date 08 December 2025

New UK/EU Rules and technologies lined up for next year

Announcement With the year ending, the UK/EU healthcare regulatory body bundled up new rules and specified the new technologies (AI/ML) adoption to achieve a successful start. The new UK clinical tr...

FDA approved enGene's solution to participate in the CMC and CDRP program
Date 05 December 2025

FDA approved enGene's solution to participate in the CMC and CDRP program

Announcement enGene Holdings Inc., a known clinical level non-viral genetic medicines company, proudly declared its detalimogene voraplasmid selection by the FDA for its Pilot program to contribute t...

PharmaTher concludes sale of Ketamine ANDA to bring the focus back to long-standing injectable ketamine franchise authorisation
Date 05 December 2025

PharmaTher concludes sale of Ketamine ANDA to bring the focus back to long-standing injectable ketamine franchise authorisation

Announcement PharmaTher Holdings Ltd., a known speciality life sciences company dedicated to unveiling the therapeutic capabilities of ketamine for neuropsychiatric disorders, has confirmed its clos...

tiakis Biotech finalised its data package to invest in the clinical trial for PAH
Date 05 December 2025

tiakis Biotech finalised its data package to invest in the clinical trial for PAH

Announcement tiakis Biotech AG, a leading clinical-level biopharmaceutical company conquering novel therapeutics for cardiovascular and life-threatening pulmonary disease, confirmed the completion o...

TempraMed inked an Exclusive Commercial Distribution deal with Dolfin
Date 05 December 2025

TempraMed inked an Exclusive Commercial Distribution deal with Dolfin

Announcement TempraMed Technologies Ltd., a leading innovator of advanced temperature-controlled medical devices, is honoured to announce its definitive exclusive distribution partnership with Dolfin...

Cleveland's IsoPSA® IVD kit received FDA approval
Date 04 December 2025

Cleveland's IsoPSA® IVD kit received FDA approval

Announcement Cleveland Diagnostics, Inc., an advanced commercial-level precision oncology company, proudly shared its FDA approval news for its IsoPSA® in vitro diagnostic (IVD) kit via the Prema...

Biolexis' clinical efforts received a call from the 2nd Innovation in Obesity Therapeutics Summit
Date 04 December 2025

Biolexis' clinical efforts received a call from the 2nd Innovation in Obesity Therapeutics Summit

Announcement Biolexis Therapeutics, an evolving champion in presenting best-in-class inflammation-targeted and next-generation metabolic therapies, proudly announced its selection for the two presen...

Ready to make better
healthcare business decisions?

Speak with a healthcare analyst about your research, consulting, or platform needs.